Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS withdrawal · 2026-03-05

Clinical Trial Update: Pharmacokinetics Safety and Acceptability of DRV/r for Children Living With HIV [Phase 1, Phase 2]

View source ↗

Summary

A Phase 1/2 clinical trial evaluating the pharmacokinetics, safety, and acceptability of the darunavir/ritonavir combination in children living with HIV was wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • darunavir/ritonavir (darunavir/ritonavir)

Snippet

Sponsor: PENTA Foundation | Conditions: HIV Infections | Phase 1, Phase 2 | Status: WITHDRAWN